The tumorigenicity of human embryonic and induced pluripotent stem cells (original) (raw)

• Dreesen, O. & Brivanlou, A. H. Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev. 3, 7–17 (2007).
  Article CAS PubMed Google Scholar
• Knoepfler, P. S. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 27, 1050–1056 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Blum, B. & Benvenisty, N. The tumorigenicity of human embryonic stem cells. Adv. Cancer Res. 100, 133–158 (2008).References 2 and 3 are recent reviews on the tumorigenicity of HESCs and possible coping strategies.
  Article PubMed Google Scholar
• Amit, M. et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271–278 (2000).
  Article CAS PubMed Google Scholar
• Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 (1998).
  Article CAS PubMed Google Scholar
• Baker, D. E. et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nature Biotech. 25, 207–215 (2007). Thorough overview of the chromosomal aberrations observed in HESCs in culture.
  Article CAS Google Scholar
• Harrison, N. J., Baker, D. & Andrews, P. W. Culture adaptation of embryonic stem cells echoes germ cell malignancy. Int. J. Androl. 30, 275–281 (2007).
  Article PubMed Google Scholar
• Hiyama, E. & Hiyama, K. Telomere and telomerase in stem cells. Br. J. Cancer 96, 1020–1024 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Eilers, M. & Eisenman, R. N. Myc's broad reach. Genes Dev. 22, 2755–2766 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Evans, P. M. & Liu, C. Roles of Krupel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim. Biophys. Sin. 40, 554–564 (2008).
  Article CAS PubMed Google Scholar
• Sperger, J. M. et al. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc. Natl Acad. Sci. USA 100, 13350–13355 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Ben-Porath, I. et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nature Genet. 40, 499–507 (2008).
  Article CAS PubMed Google Scholar
• Wong, D. J. et al. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2, 333–344 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Neveu, P. et al. MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states. Cell Stem Cell 7, 671–681 (2010).
  Article CAS PubMed Google Scholar
• Calvanese, V. et al. Cancer genes hypermethylated in human embryonic stem cells. PLoS ONE 3, e3294 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Bjorklund, L. M. et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl Acad. Sci. USA 99, 2344–2349 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Herszfeld, D. et al. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nature Biotech. 24, 351–357 (2006).
  Article CAS Google Scholar
• Yang, S. et al. Tumor progression of culture-adapted human embryonic stem cells during long-term culture. Genes Chromosomes Cancer 47, 665–679 (2008).
  Article CAS PubMed Google Scholar
• Werbowetski-Ogilvie, T. E. et al. Characterization of human embryonic stem cells with features of neoplastic progression. Nature Biotech. 27, 91–97 (2009). First demonstration of altered proliferation and differentiation capacities in adapted HESC lines with subkaryotypic genetic abnormalities.
  Article CAS Google Scholar
• Blum, B. & Benvenisty, N. The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle 8, 3822–3830 (2009). Recent perspective of the tumorigenicity of HESCs and its relationship with genomic instability of HESCs in culture.
  Article CAS PubMed Google Scholar
• Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78, 7634–7638 (1981).
  Article CAS PubMed PubMed Central Google Scholar
• Shih, C. C., Forman, S. J., Chu, P. & Slovak, M. Human embryonic stem cells are prone to generate primitive, undifferentiated tumors in engrafted human fetal tissues in severe combined immunodeficient mice. Stem Cells Dev. 16, 893–902 (2007).
  Article CAS PubMed Google Scholar
• Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).
  Article CAS PubMed Google Scholar
• Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
  Article CAS PubMed Google Scholar
• Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
  Article CAS PubMed Google Scholar
• Chin, M. H. et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5, 111–123 (2009). First study describing global gene expression differences between HESCs and HiPSCs.
  Article CAS PubMed PubMed Central Google Scholar
• Urbach, A., Bar-Nur, O., Daley, G. Q. & Benvenisty, N. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 6, 407–411 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Polo, J. M. et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nature Biotech. 28, 848–855 (2010).
  Article CAS Google Scholar
• Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285–290 (2010). References 28 and 29 are comprehensive studies describing epigenetic memory in mouse iPSCs.
  Article CAS PubMed PubMed Central Google Scholar
• Pick, M. et al. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 27, 2686–2690 (2009).
  Article CAS PubMed Google Scholar
• Albihn, A., Johnsen, J. I. & Henriksson, M. A. MYC in oncogenesis and as a target for cancer therapies. Adv. Cancer Res. 107, 163–224 (2010).
  Article CAS PubMed Google Scholar
• Ruggero, D. The role of Myc-induced protein synthesis in cancer. Cancer Res. 69, 8839–8843 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Tian, Y. et al. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J. Biol. Chem. 285, 7986–7994 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Lambertini, C., Pantano, S. & Dotto, G. P. Differential control of Notch1 gene transcription by Klf4 and Sp3 transcription factors in normal versus cancer-derived keratinocytes. PLoS ONE 5, e10369 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Rageul, J. et al. KLF4-dependent, PPARγ-induced expression of GPA33 in colon cancer cell lines. Int. J. Cancer 125, 2802–2809 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Asadi, M. H. et al. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an anti-apoptotic factor. Int. J. Cancer 3 Nov 2010 (doi:10.1002/ijc.25643).
• Wang, Y. et al. Oct-4B isoform is differentially expressed in breast cancer cells: hypermethylation of regulatory elements of Oct-4A suggests an alternative promoter and transcriptional start site for Oct-4B transcription. Biosci. Rep. 31, 109–115 (2010).
  Article CAS Google Scholar
• Peng, S., Maihle, N. J. & Huang, Y. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 29, 2153–2159 (2010).
  Article CAS PubMed Google Scholar
• Sholl, L. M., Barletta, J. A., Yeap, B. Y., Chirieac, L. R. & Hornick, J. L. Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma. Am. J. Surg. Pathol. 34, 1193–1198 (2010).
  Article PubMed PubMed Central Google Scholar
• Ji, J. & Zheng, P. S. Expression of Sox2 in human cervical carcinogenesis. Hum. Pathol. 41, 1438–1447 (2010).
  Article CAS PubMed Google Scholar
• Schoenhals, M. et al. Embryonic stem cell markers expression in cancers. Biochem. Biophys. Res. Commun. 383, 157–162 (2009).
  Article CAS PubMed Google Scholar
• Ramos-Mejia, V., Munoz-Lopez, M., Garcia-Perez, J. L. & Menendez, P. iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability. Cell Res. 20, 1092–1095 (2010).
  Article PubMed Google Scholar
• Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotech. 26, 101–106 (2008).
  Article CAS Google Scholar
• Nakagawa, M., Takizawa, N., Narita, M., Ichisaka, T. & Yamanaka, S. Promotion of direct reprogramming by transformation-deficient Myc. Proc. Natl Acad. Sci. USA 107, 14152–14157 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Li, W. et al. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 27, 2992–3000 (2009).
  CAS PubMed PubMed Central Google Scholar
• Li, W. et al. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4, 16–19 (2009).
  Article PubMed CAS Google Scholar
• Huangfu, D. et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nature Biotech. 26, 1269–1275 (2008).
  Article CAS Google Scholar
• Zhu, S. et al. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 7, 651–655 (2010).
  Article CAS PubMed Google Scholar
• Marion, R. M. et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460, 1149–1153 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Utikal, J. et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460, 1145–1148 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hong, H. et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460, 1132–1135 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Li, H. et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460, 1136–1139 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kawamura, T. et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140–1144 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Menendez, S., Camus, S. & Belmonte, J. C. p53: guardian of reprogramming. Cell Cycle 9, 3887–3891 (2010).
  Article CAS PubMed Google Scholar
• Marion, R. M. et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4, 141–154 (2009).
  Article CAS PubMed Google Scholar
• Yehezkel, S. et al. Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics 6, 63–75 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Vera, E., Canela, A., Fraga, M. F., Esteller, M. & Blasco, M. A. Epigenetic regulation of telomeres in human cancer. Oncogene 27, 6817–6833 (2008).
  Article CAS PubMed Google Scholar
• Doi, A. et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nature Genet. 41, 1350–1353 (2009).
  Article CAS PubMed Google Scholar
• Aoi, T. et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321, 699–702 (2008).
  Article CAS PubMed Google Scholar
• Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. & Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science 322, 945–949 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. & Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949–953 (2008).
  Article CAS PubMed Google Scholar
• Kaji, K. et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458, 771–775 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, J. et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797–801 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Woltjen, K. et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458, 766–770 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Soldner, F. et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964–977 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, H. et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381–384 (2009).
  Article CAS PubMed Google Scholar
• Kim, D. et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4, 472–476 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618–630 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Mayshar, Y. et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7, 521–531 (2010). First comprehensive study of chromosomal aberrations observed in HiPSCs in culture.
  Article CAS PubMed Google Scholar
• Draper, J. S., Moore, H. D., Ruban, L. N., Gokhale, P. J. & Andrews, P. W. Culture and characterization of human embryonic stem cells. Stem Cells Dev. 13, 325–336 (2004).
  Article CAS PubMed Google Scholar
• Maitra, A. et al. Genomic alterations in cultured human embryonic stem cells. Nature Genet. 37, 1099–1103 (2005).
  Article CAS PubMed Google Scholar
• Lefort, N. et al. Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nature Biotech. 26, 1364–1366 (2008).
  Article CAS Google Scholar
• Spits, C. et al. Recurrent chromosomal abnormalities in human embryonic stem cells. Nature Biotech. 26, 1361–1363 (2008).
  Article CAS Google Scholar
• Inzunza, J. et al. Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation. Mol. Hum. Reprod. 10, 461–466 (2004).
  Article CAS PubMed Google Scholar
• Lefort, N., Perrier, A. L., Laabi, Y., Varela, C. & Peschanski, M. Human embryonic stem cells and genomic instability. Regen. Med. 4, 899–909 (2009). Recent review on the genomic instability of HESCs.
  Article PubMed Google Scholar
• Narva, E. et al. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nature Biotech. 28, 371–377 (2010).
  Article CAS Google Scholar
• Gertow, K. et al. Trisomy 12 in HESC leads to no selective in vivo growth advantage in teratomas, but induces an increased abundance of renal development. J. Cell. Biochem. 100, 1518–1525 (2007).
  Article CAS PubMed Google Scholar
• Moon, S. H. et al. Effect of chromosome instability on the maintenance and differentiation of human embryonic stem cells in vitro and in vivo. Stem Cell Res. 6, 50–59 (2011).
  Article CAS PubMed Google Scholar
• Laurent, L. C. et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8, 106–118 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Moriguchi, H., Chung, R. T. & Sato, C. Tumorigenicity of human induced pluripotent stem cells depends on the balance of gene expression between p21 and p53. Hepatology 51, 1088–1089 (2010).
  Article PubMed Google Scholar
• Ben-David, U., Benvenisty, N. & Mayshar, Y. Genetic instability in human induced pluripotent stem cells: classification of causes and possible safeguards. Cell Cycle 9, 4603–4604 (2010).
  Article CAS PubMed Google Scholar
• Chin, M. H., Pellegrini, M., Plath, K. & Lowry, W. E. Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell 7, 263–269 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Guenther, M. G. et al. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7, 249–257 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Newman, A. M. & Cooper, J. B. Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell 7, 258–262 (2010).
  Article CAS PubMed Google Scholar
• Malchenko, S. et al. Cancer hallmarks in induced pluripotent cells: new insights. J. Cell. Physiol. 225, 390–393 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ohm, J. E. et al. Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells. Cancer Res. 70, 7662–7673 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Hu, Q., Friedrich, A. M., Johnson, L. V. & Clegg, D. O. Memory in induced pluripotent stem cells: reprogrammed human retinal pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells 28, 1981–1991 (2010).
  Article CAS PubMed Google Scholar
• Ghosh, Z. et al. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS ONE 5, e8975 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Ron-Bigger, S. et al. Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming. Stem Cells 28, 1349–1354 (2010).
  Article CAS PubMed Google Scholar
• Jirtle, R. L. Genomic imprinting and cancer. Exp. Cell Res. 248, 18–24 (1999).
  Article CAS PubMed Google Scholar
• Lim, D. H. & Maher, E. R. Genomic imprinting syndromes and cancer. Adv. Genet. 70, 145–175 (2010).
  Article CAS PubMed Google Scholar
• Stadtfeld, M. et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465, 175–181 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Rugg-Gunn, P. J., Ferguson-Smith, A. C. & Pedersen, R. A. Epigenetic status of human embryonic stem cells. Nature Genet. 37, 585–587 (2005).
  Article CAS PubMed Google Scholar
• Rugg-Gunn, P. J., Ferguson-Smith, A. C. & Pedersen, R. A. Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines. Hum. Mol. Genet. 16, R243–R251 (2007).
  Article CAS PubMed Google Scholar
• Adewumi, O. et al. Characterization of human embryonic stem cell lines by the International Stem CellInitiative. Nature Biotech. 25, 803–816 (2007).
  Article CAS Google Scholar
• Frost, J. M. et al. The effects of culture on genomic imprinting profiles in human embryonic and fetal mesenchymal stem cells. Epigenetics 6, 52–62 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Ghule, P. N. et al. Reprogramming the pluripotent cell cycle: restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cells. J. Cell. Physiol. 13 Oct 2010 (doi:10.1002/jcp.22440).
• Singh, A. M. & Dalton, S. The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell 5, 141–149 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Neganova, I., Zhang, X., Atkinson, S. & Lako, M. Expression and functional analysis of G1 to S. regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells. Oncogene 28, 20–30 (2009).
  Article CAS PubMed Google Scholar
• Edel, M. J. et al. Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1. Genes Dev. 24, 561–573 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Holubcova, Z. et al. Human embryonic stem cells suffer from centrosomal amplification. Stem Cells 29, 46–56 (2011).
  Article CAS PubMed Google Scholar
• Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313–317 (2007).
  Article CAS PubMed Google Scholar
• Wernig, M., Meissner, A., Cassady, J. P. & Jaenisch, R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2, 10–12 (2008).
  Article CAS PubMed Google Scholar
• Mali, P. et al. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells 26, 1998–2005 (2008).
  Article CAS PubMed Google Scholar
• Miura, K. et al. Variation in the safety of induced pluripotent stem cell lines. Nature Biotech. 27, 743–745 (2009). First comparison of the tumorigenicity of mouse iPSCs from different somatic origins.
  Article CAS Google Scholar
• Moriguchi, H., Chung, R. T. & Sato, C. An indicator for evaluating the risk of cancerous transformations of human induced pluripotent stem cells. Hepatology 51, 1085–1086 (2010).
  PubMed Google Scholar
• Gutierrez-Aranda, I. et al. Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. Stem Cells 28, 1568–1570 (2010). Along with reference 86, this is one of the studies directly comparing the tumorigenicity of HESCs and HiPSCs.
  Article PubMed PubMed Central Google Scholar
• Hentze, H., Graichen, R. & Colman, A. Cell therapy and the safety of embryonic stem cell-derived grafts. Trends Biotechnol. 25, 24–32 (2007).
  Article CAS PubMed Google Scholar
• Lee, A. S. et al. Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle 8, 2608–2612 (2009).
  Article CAS PubMed Google Scholar
• Hentze, H. et al. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res. 2, 198–210 (2009).
  Article PubMed Google Scholar
• Eiges, R. et al. Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr. Biol. 11, 514–518 (2001).
  Article CAS PubMed Google Scholar
• Choo, A. B. et al. Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. Stem Cells 26, 1454–1463 (2008).
  Article CAS PubMed Google Scholar
• Tan, H. L., Fong, W. J., Lee, E. H., Yap, M. & Choo, A. mAb 84, a cytotoxic antibody that kills undifferentiated human embryonic stem cells via oncosis. Stem Cells 27, 1792–1801 (2009).
  Article CAS PubMed Google Scholar
• Fong, C. Y., Peh, G. S., Gauthaman, K. & Bongso, A. Separation of SSEA-4 and TRA-1-60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS). Stem Cell Rev. 5, 72–80 (2009).
  Article CAS Google Scholar
• Blum, B., Bar-Nur, O., Golan-Lev, T. & Benvenisty, N. The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nature Biotech. 27, 281–287 (2009).
  Article CAS Google Scholar
• Smith, K. N., Singh, A. M. & Dalton, S. Myc represses primitive endoderm differentiation in pluripotent stem cells. Cell Stem Cell 7, 343–354 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Varlakhanova, N. V. et al. myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation 80, 9–19 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Smith, K. & Dalton, S. Myc transcription factors: key regulators behind establishment and maintenance of pluripotency. Regen. Med. 5, 947–959 (2010).
  Article CAS PubMed Google Scholar
• Kim, J. et al. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 143, 313–324 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Schuldiner, M., Itskovitz-Eldor, J. & Benvenisty, N. Selective ablation of human embryonic stem cells expressing a “suicide” gene. Stem Cells 21, 257–265 (2003).
  Article CAS PubMed Google Scholar
• Krishna, K. A., Rao, G. V. & Rao, K. S. Stem cell-based therapy for the treatment of Type 1 diabetes mellitus. Regen. Med. 2, 171–177 (2007).
  Article CAS PubMed Google Scholar
• Korsgren, O. & Nilsson, B. Improving islet transplantation: a road map for a widespread application for the cure of persons with type I diabetes. Curr. Opin. Organ Transplant. 14, 683–687 (2009).
  Article PubMed Google Scholar
• Dean, S. K., Yulyana, Y., Williams, G., Sidhu, K. S. & Tuch, B. E. Differentiation of encapsulated embryonic stem cells after transplantation. Transplantation 82, 1175–1184 (2006).
  Article PubMed Google Scholar
• Giorgetti, A. et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5, 353–357 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, J. B. et al. Direct reprogramming of human neural stem cells by OCT4. Nature 461, 649–653 (2009).
  Article CAS PubMed Google Scholar
• Russo, E. Follow the money—the politics of embryonic stem cell research. PLoS Biol. 3, e234 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Hussein, S.M et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58–62 (2011).
  Article CAS PubMed Google Scholar
• Gore, A. et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63–67 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Lister, R. et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68–73 (2011).
  Article CAS PubMed PubMed Central Google Scholar